Clinical trial
Non-interventional Study of Patients With Netherton Syndrome to Characterise the Natural History of Disease
NCT05902663 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Non-interventional Study of Patients With Netherton Syndrome to Characterise the Natural History of Disease
- Lead sponsor
- Boehringer Ingelheim
- Phase
- Observational
- Overall status
- Terminated
- Start date
- October 9, 2024
- Completion date
- March 31, 2025
- Enrollment
- 4 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.